Enter inventor name

Anthony E Pegg

This inventor holds 17 USPTO granted patents and 1 EPO patent. Top assignees: The Penn State Research Foundation, Arch Development Corporation, The United States of America as Represented by the Department of Health. Active years: 1992-2014.

USPTO Granted Patents = 17

% Patents Active = 88.2

EPO Patents = 1

Average Co-Inventor Count = 3.8

ph-index = 7

Forward Citations = 121(Granted Patents)

Company Filing History:

11 out of 1,338

The Penn State Research Foundation

patents

6 out of 349

Arch Development Corporation

patents

5 out of 1,217

The United States of America as Represented by the Department of Health

patents

4. 3 out of 2,202

The United States of America as Represented by the Secretary of

patents

5. 2 out of 3,688

The United States of America, as Represented by the Secretary, Department of Health and Human Services

H. Lee Moffitt Cancer Center and Research Institute, Inc.

patents

8. 1 out of 205

Southern Research Institute

patents

9. 1 out of 1

The of the United States of America as Represented by the Department of

patent

10. 4 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2014

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8637485 - 5',-substituted adenosynes preparation thereof and use as inhibitors of S-adenosylmethionine decarboxylase (2014-01-28),

2. 8188055 - Inactivators of O6-alkylguanine-DNA alkyltransferase (2012-05-29),

3. 7825096 - O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs (2010-11-02),

4. 6436945 - Substituted O6-benzyl-8-aza-guanines (2002-08-20),

5. 6333331 - Substituted O6-benzylguanines (2001-12-25),

6. 6303604 - Pharmaceutical composition comprising 2,4-diamino-6-benzyloxy-s-triazine and inactivation of O6-alkylguanine-DNA-alkyltransferase (2001-10-16),

7. 6172070 - Substituted O6-benzyl-8-aza-guanines and 6(4)-benzyloxypyrimidines (2001-01-09),

8. 6060458 - Oligodeoxyribonucleotides comprising O.sup.6 -benzylguanine and their use (2000-05-09),

9. 5965126 - use of mutant alkyltransferases for gene therapy to protect from (1999-10-12),

10. 5958932 - Substitutes O.sup.6 -benzylguanines, compositions, and methods of using (1999-09-28),

11. 5916894 - Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines (1999-06-29),

12. 5753668 - Substituted benzyloxypyrimidines and their inactivation of O.sup.6 (1998-05-19),

13. 5691307 - O.sup.6 -substituted guanine compositions and methods for depleting O.sup.6 (1997-11-25),

14. 5525606 - Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines (1996-06-11),

15. 5358952 - O.sup.6 -substituted guanine compounds and methods for depleting O.sup.6 (1994-10-25),

Title: The Innovative Journey of Anthony E Pegg

Introduction: Anthony E Pegg, a talented inventor based in Hershey, PA (US), has made significant contributions to the field of innovations with his creative mind and dedication to problem-solving.

Latest Patents: Anthony E Pegg holds several patents in various industries, showcasing his versatility and ingenuity in inventing new solutions to complex challenges.

Career Highlights: Throughout his career, Anthony E Pegg has demonstrated a keen ability to identify gaps in the market and develop groundbreaking inventions to fill those voids. His passion for innovation has led to the creation of revolutionary products that have improved the lives of many.

Collaborations: Anthony E Pegg has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His collaborative spirit and willingness to work with others have been instrumental in the success of his projects.

Conclusion: Anthony E Pegg's remarkable journey as an inventor is a testament to his unwavering commitment to pushing the boundaries of what is possible through innovation. His impact on the world of inventions is truly inspiring, and his legacy will continue to influence future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]